Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Tuberculosis | Study Protocol

The burden and natural history of cardiac pathology at TB diagnosis in a high-HIV prevalence district in Zambia: protocol for the TB-Heart study

Authors: Marcello S. Scopazzini, Pamela Chansa, Edith D. Majonga, Nina Bual, Albertus Schaap, Kondwelani J. Mateyo, Remmy Musukuma, Veronica Mweemba, Maina Cheeba, Chipili C. Mwila, Lucheka Sigande, Isabel Banda, Joseph Ngulube, Kwame Shanaube, Dominik Zenner, Helen Ayles, Anoop S. V. Shah

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

Tuberculosis (TB) continues to be a major cause of death across sub-Saharan Africa (SSA). In parallel, non-communicable disease and especially cardiovascular disease (CVD) burden has increased substantially in the region. Cardiac manifestations of TB are well-recognised but the extent to which they co-exist with pulmonary TB (PTB) has not been systematically evaluated. The aim of this study is to improve understanding of the burden of cardiac pathology in PTB in those living with and without HIV in a high-burden setting.

Methods

This is a cross-sectional and natural history study to evaluate the burden and natural history of cardiac pathology in participants with PTB in Lusaka, Zambia, a high burden setting for TB and HIV. Participants with PTB, with and without HIV will be consecutively recruited alongside age- and sex-matched TB-uninfected comparators on a 2:1 basis. Participants will undergo baseline assessments to collect clinical, socio-demographic, functional, laboratory and TB disease impact data followed by point-of-care and standard echocardiography. Participants with PTB will undergo further repeat clinical and functional examination at two- and six months follow-up. Those with cardiac pathology at baseline will undergo repeat echocardiography at six months.

Discussion

The outcomes of the study are to a) determine the burden of cardiac pathology at TB diagnosis, b) describe its association with patient-defining risk factors and biochemical markers of cardiac injury and stretch and c) describe the natural history of cardiac pathology during the course of TB treatment.
Literature
1.
go back to reference Law I, Floyd K. National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned. Trop Med Int Health. 2020;25(11):1308–27.CrossRefPubMedPubMedCentral Law I, Floyd K. National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned. Trop Med Int Health. 2020;25(11):1308–27.CrossRefPubMedPubMedCentral
2.
go back to reference Organization WH. Global Tuberculosis Report 2021. Geneva: WHO; 2021. Organization WH. Global Tuberculosis Report 2021. Geneva: WHO; 2021.
3.
go back to reference Organization WH. WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025: background document. Geneva: World Health Organization; 2021. Organization WH. WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025: background document. Geneva: World Health Organization; 2021.
4.
go back to reference Basham CA, Smith SJ, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PLoS ONE. 2020;15(7):e0235821.CrossRefPubMedPubMedCentral Basham CA, Smith SJ, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PLoS ONE. 2020;15(7):e0235821.CrossRefPubMedPubMedCentral
5.
go back to reference Burgos LM, Farina J, Liendro MC, Saldarriaga C, Liprandi AS, Wyss F, et al. Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design. Global Heart. 2020;15(1). Burgos LM, Farina J, Liendro MC, Saldarriaga C, Liprandi AS, Wyss F, et al. Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design. Global Heart. 2020;15(1).
6.
go back to reference Erqou S, Lodebo BT, Masri A, Altibi AM, Echouffo-Tcheugui JB, Dzudie A, et al. Cardiac Dysfunction Among People Living With HIV: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2019;7(2):98–108.CrossRefPubMed Erqou S, Lodebo BT, Masri A, Altibi AM, Echouffo-Tcheugui JB, Dzudie A, et al. Cardiac Dysfunction Among People Living With HIV: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2019;7(2):98–108.CrossRefPubMed
7.
go back to reference Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005;112(23):3577–83.CrossRefPubMed Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005;112(23):3577–83.CrossRefPubMed
8.
go back to reference Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective. Glob Heart. 2020;15(1):15.CrossRefPubMedPubMedCentral Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective. Glob Heart. 2020;15(1):15.CrossRefPubMedPubMedCentral
9.
go back to reference Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Prim. 2016;2(1):16076.CrossRefPubMed Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Prim. 2016;2(1):16076.CrossRefPubMed
10.
go back to reference Lopez-Lopez JP, Posada-Martinez EL, Saldarriaga C, Wyss F, Ponte-Negretti CI, Alexander B, et al. Tuberculosis and the heart. J Am Heart Assoc. 2021;10(7):e019435.CrossRefPubMedPubMedCentral Lopez-Lopez JP, Posada-Martinez EL, Saldarriaga C, Wyss F, Ponte-Negretti CI, Alexander B, et al. Tuberculosis and the heart. J Am Heart Assoc. 2021;10(7):e019435.CrossRefPubMedPubMedCentral
12.
go back to reference UNAIDS. Country Progress Report - Zambia. 2020. UNAIDS. Country Progress Report - Zambia. 2020.
13.
go back to reference Health Mo. Zambia STEPS for Non Communicable Diseases Risk Factors: Zambia Report for 2017. Zambia: Ministry of Health 2018. Health Mo. Zambia STEPS for Non Communicable Diseases Risk Factors: Zambia Report for 2017. Zambia: Ministry of Health 2018.
14.
go back to reference Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Lancet Infect Dis. 2015;15(5):544–51.CrossRefPubMed Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Lancet Infect Dis. 2015;15(5):544–51.CrossRefPubMed
15.
go back to reference Mucheleng’Anga LA, Himwaze CM, Telendiy V, Simumba S, Soko J, Kayonde N, et al. Incidental Tuberculosis in sudden, unexpected, and violent deaths in the community Lusaka, Zambia - A descriptive forensic post-mortem examination study. Int J Infect Dis. 2022;124:S75–81.CrossRefPubMed Mucheleng’Anga LA, Himwaze CM, Telendiy V, Simumba S, Soko J, Kayonde N, et al. Incidental Tuberculosis in sudden, unexpected, and violent deaths in the community Lusaka, Zambia - A descriptive forensic post-mortem examination study. Int J Infect Dis. 2022;124:S75–81.CrossRefPubMed
16.
go back to reference Narasimhan P, Wood J, Macintyre CR, Mathai D. Risk Factors for Tuberculosis. Pulm Med. 2013;2013:1–11.CrossRef Narasimhan P, Wood J, Macintyre CR, Mathai D. Risk Factors for Tuberculosis. Pulm Med. 2013;2013:1–11.CrossRef
17.
go back to reference Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, Maartens G, Mcilleron H, et al. Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors. BMC Infect Dis. 2010;10(1):83.CrossRefPubMedPubMedCentral Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, Maartens G, Mcilleron H, et al. Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors. BMC Infect Dis. 2010;10(1):83.CrossRefPubMedPubMedCentral
18.
go back to reference Majonga ED, Rehman AM, Simms V, McHugh G, Mujuru HA, Nathoo K, et al. High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy. AIDS. 2018;32(18):2739–48.CrossRefPubMed Majonga ED, Rehman AM, Simms V, McHugh G, Mujuru HA, Nathoo K, et al. High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy. AIDS. 2018;32(18):2739–48.CrossRefPubMed
19.
go back to reference Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J. 2012;33(7):866–74.CrossRefPubMed Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J. 2012;33(7):866–74.CrossRefPubMed
20.
go back to reference Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018;138(11):1100–12.CrossRefPubMedPubMedCentral Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018;138(11):1100–12.CrossRefPubMedPubMedCentral
21.
go back to reference Hudson JA, Majonga ED, Ferrand RA, Perel P, Alam SR, Shah ASV. Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review. JAMA. 2022;328(10):951–62.CrossRefPubMedPubMedCentral Hudson JA, Majonga ED, Ferrand RA, Perel P, Alam SR, Shah ASV. Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review. JAMA. 2022;328(10):951–62.CrossRefPubMedPubMedCentral
22.
go back to reference Rudolf F, Lemvik G, Abate E, Verkuilen J, Schön T, Gomes VF, et al. TBscore II: Refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis. Scand J Infect Dis. 2013;45(11):825–36.CrossRefPubMed Rudolf F, Lemvik G, Abate E, Verkuilen J, Schön T, Gomes VF, et al. TBscore II: Refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis. Scand J Infect Dis. 2013;45(11):825–36.CrossRefPubMed
23.
go back to reference Society AT. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.CrossRef Society AT. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.CrossRef
25.
go back to reference Ahmed AE, Ibrahim AS, Elshafie SM. Pulmonary hypertension in patients with treated pulmonary tuberculosis: analysis of 14 consecutive cases. Clin Med Insights Circ Respir Pulm Med. 2011;5:1–5.CrossRefPubMedPubMedCentral Ahmed AE, Ibrahim AS, Elshafie SM. Pulmonary hypertension in patients with treated pulmonary tuberculosis: analysis of 14 consecutive cases. Clin Med Insights Circ Respir Pulm Med. 2011;5:1–5.CrossRefPubMedPubMedCentral
26.
go back to reference Allwood BW, Manie S, Stolbrink M, Hunter L, Matthee S, Meintjes G, et al. Pulmonary hypertension in adults completing tuberculosis treatment. Afr J Thorac Crit Care Med. 2023;29(3). Allwood BW, Manie S, Stolbrink M, Hunter L, Matthee S, Meintjes G, et al. Pulmonary hypertension in adults completing tuberculosis treatment. Afr J Thorac Crit Care Med. 2023;29(3).
27.
go back to reference Casas E, Blanco JR, Ibarra V, Metola L, Rosel L, Oteo JA. Incidence of pericardial effusion in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4(12):1173–5.PubMed Casas E, Blanco JR, Ibarra V, Metola L, Rosel L, Oteo JA. Incidence of pericardial effusion in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4(12):1173–5.PubMed
28.
go back to reference Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2433–43.CrossRefPubMedPubMedCentral Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2433–43.CrossRefPubMedPubMedCentral
29.
go back to reference Kotresh NR, Jaligidad K. Study of prevalence of cor pulmonale in patients with pulmonary tuberculosis with reference to ECG, echocardiographic changes and radiological extent of the disease. Int J Med Res. 2016;1(3):27–9. Kotresh NR, Jaligidad K. Study of prevalence of cor pulmonale in patients with pulmonary tuberculosis with reference to ECG, echocardiographic changes and radiological extent of the disease. Int J Med Res. 2016;1(3):27–9.
30.
go back to reference Marjani M, Baghaei P, Malekmohammad M, Tabarsi P, Sharif-Kashani B, Behzadnia N, et al. Effect of pulmonary hypertension on outcome of pulmonary tuberculosis. Braz J Infect Dis. 2014;18(5):487–90.CrossRefPubMedPubMedCentral Marjani M, Baghaei P, Malekmohammad M, Tabarsi P, Sharif-Kashani B, Behzadnia N, et al. Effect of pulmonary hypertension on outcome of pulmonary tuberculosis. Braz J Infect Dis. 2014;18(5):487–90.CrossRefPubMedPubMedCentral
31.
go back to reference Patil SV, Toshniwal S, Acharya A, Gondhali G. Cardiac dysfunction in active pulmonary tuberculosis: Mysterious facts of TB’s pandora. Electronic Journal of General Medicine. 2023;20(2). Patil SV, Toshniwal S, Acharya A, Gondhali G. Cardiac dysfunction in active pulmonary tuberculosis: Mysterious facts of TB’s pandora. Electronic Journal of General Medicine. 2023;20(2).
32.
go back to reference Ahmed HA, Mohamed J, Akuku IG, Lee KK, Alam SR, Perel P, et al. Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study. BMJ Open. 2022;12(6):e062352.CrossRefPubMedPubMedCentral Ahmed HA, Mohamed J, Akuku IG, Lee KK, Alam SR, Perel P, et al. Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study. BMJ Open. 2022;12(6):e062352.CrossRefPubMedPubMedCentral
33.
go back to reference Alvi RM, Zanni MV, Neilan AM, Hassan MZ, Tariq N, Zhang L, et al. N-terminal pro-b-type natriuretic peptide among patients living with both hiv and heart failure. Circulation. 2019;140(Supplement 1). Alvi RM, Zanni MV, Neilan AM, Hassan MZ, Tariq N, Zhang L, et al. N-terminal pro-b-type natriuretic peptide among patients living with both hiv and heart failure. Circulation. 2019;140(Supplement 1).
34.
go back to reference Alvi RM, Zanni MV, Neilan AM, Hassan MZO, Tariq N, Zhang L, et al. Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019. Alvi RM, Zanni MV, Neilan AM, Hassan MZO, Tariq N, Zhang L, et al. Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019.
35.
go back to reference Kahn D, Pool KL, Phiri L, Chibwana F, Schwab K, Longwe L, et al. Diagnostic Utility and Impact on Clinical Decision Making of Focused Assessment With Sonography for HIV-Associated Tuberculosis in Malawi: A Prospective Cohort Study. Glob Health Sci Pract. 2020;8(1):28–37.CrossRefPubMedPubMedCentral Kahn D, Pool KL, Phiri L, Chibwana F, Schwab K, Longwe L, et al. Diagnostic Utility and Impact on Clinical Decision Making of Focused Assessment With Sonography for HIV-Associated Tuberculosis in Malawi: A Prospective Cohort Study. Glob Health Sci Pract. 2020;8(1):28–37.CrossRefPubMedPubMedCentral
Metadata
Title
The burden and natural history of cardiac pathology at TB diagnosis in a high-HIV prevalence district in Zambia: protocol for the TB-Heart study
Authors
Marcello S. Scopazzini
Pamela Chansa
Edith D. Majonga
Nina Bual
Albertus Schaap
Kondwelani J. Mateyo
Remmy Musukuma
Veronica Mweemba
Maina Cheeba
Chipili C. Mwila
Lucheka Sigande
Isabel Banda
Joseph Ngulube
Kwame Shanaube
Dominik Zenner
Helen Ayles
Anoop S. V. Shah
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-03877-0

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue